Fahc Outpatient Pharmacy - Medicare Supplier in Colchester, VT

Fahc Outpatient Pharmacy is a medicare enrolled Pharmacy in Colchester, Vermont. It is located at 792 College Pkwy 103, Colchester, Vermont 05446. You can reach out to the office of Fahc Outpatient Pharmacy via phone at (802) 847-7461. Fahc Outpatient Pharmacy supplies medicare equipments and products such as Blood Glucose Monitors & Supplies: Non-Mail Order, Blood Glucose Monitors & Supplies: Mail Order, etc. The legal business name for Fahc Outpatient Pharmacy is University Of Vermont Medical Center Inc.

Contact Information

Fahc Outpatient Pharmacy
792 College Pkwy 103, Colchester, Vermont 05446
(802) 847-7461


Supplier Profile

NameFahc Outpatient Pharmacy
Organization NameUniversity Of Vermont Medical Center Inc
Location792 College Pkwy 103, Colchester, Vermont 05446
TypePharmacy
Phone(802) 847-7461
Participate in MedicareMedicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier.

News Archive

NIH awards Johns Hopkins Epigenetic Center $16.8M to advance genomics research

Johns Hopkins' Center for the Epigenetics of Common Human Disease has been chosen as one of four recipients of a $45 million National Institutes of Health (NIH) grant for Centers of Excellence to advance genomics research. The Hopkins Center will receive $16.8 million over five years.

Transgenic mouse model validates mutant IDH2 protein as candidate for targeted anticancer therapies

In recent years, mutations in two metabolic enzymes, isocitrate dehydrogenase-1 and 2 (IDH1 and IDH2), have been identified in approximately 20 percent of all acute myeloid leukemias (AML). As a result, mutant IDH proteins have been proposed as attractive drug targets for this common form of adult leukemia.

Study shows how neutralizing antibodies are produced after SARS-CoV-2 infection

A research group from Osaka University led by Professor Hisashi Arase and consisting of researchers from the Research Institute for Microbial Diseases, the Institute for Protein Research, the Immunology Frontier Research Center, the Center for Infectious Diseases, and the Graduate School of Medicine has discovered for the first time that both neutralizing antibodies that protect against infection as well as infection-enhancing antibodies that increase infectivity are produced after infection with SARS-CoV-2 by analyzing antibodies derived from COVID-19 patients.

Poll: Opposition to health law grows

The Associated Press: "A new Associated Press-GfK poll finds Americans oppose the health care remake 50 percent to 39 percent. Before a divided Congress finally passed the bill and Obama signed it at a jubilant White House ceremony last month, public opinion was about evenly split. Another 10 percent of Americans say they are neutral."

Read more Medical News

› Verified 1 days ago

Products, Equipments, Supplies available at this Supplier:

Fahc Outpatient Pharmacy supplies following medicare products, supplies and equipments -
  • Blood Glucose Monitors & Supplies: Mail Order
  • Blood Glucose Monitors & Supplies: Non-Mail Order

NPI Associated with this Supplier:

Suppliers may have multiple NPI numbers. We have found possible NPI number/s associated with Fahc Outpatient Pharmacy from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1407867054
Organization NameUNIVERSITY OF VERMONT MEDICAL CENTER INC
Doing Business AsUVM MEDICAL CENTER OUTPATIENT PHARMACY
TypePharmacy
Address792 College Pkwy, Colchester, VT 05446
Phone Number802-847-7461

News Archive

NIH awards Johns Hopkins Epigenetic Center $16.8M to advance genomics research

Johns Hopkins' Center for the Epigenetics of Common Human Disease has been chosen as one of four recipients of a $45 million National Institutes of Health (NIH) grant for Centers of Excellence to advance genomics research. The Hopkins Center will receive $16.8 million over five years.

Transgenic mouse model validates mutant IDH2 protein as candidate for targeted anticancer therapies

In recent years, mutations in two metabolic enzymes, isocitrate dehydrogenase-1 and 2 (IDH1 and IDH2), have been identified in approximately 20 percent of all acute myeloid leukemias (AML). As a result, mutant IDH proteins have been proposed as attractive drug targets for this common form of adult leukemia.

Study shows how neutralizing antibodies are produced after SARS-CoV-2 infection

A research group from Osaka University led by Professor Hisashi Arase and consisting of researchers from the Research Institute for Microbial Diseases, the Institute for Protein Research, the Immunology Frontier Research Center, the Center for Infectious Diseases, and the Graduate School of Medicine has discovered for the first time that both neutralizing antibodies that protect against infection as well as infection-enhancing antibodies that increase infectivity are produced after infection with SARS-CoV-2 by analyzing antibodies derived from COVID-19 patients.

Poll: Opposition to health law grows

The Associated Press: "A new Associated Press-GfK poll finds Americans oppose the health care remake 50 percent to 39 percent. Before a divided Congress finally passed the bill and Obama signed it at a jubilant White House ceremony last month, public opinion was about evenly split. Another 10 percent of Americans say they are neutral."

Read more Medical News

› Verified 1 days ago

News Archive

NIH awards Johns Hopkins Epigenetic Center $16.8M to advance genomics research

Johns Hopkins' Center for the Epigenetics of Common Human Disease has been chosen as one of four recipients of a $45 million National Institutes of Health (NIH) grant for Centers of Excellence to advance genomics research. The Hopkins Center will receive $16.8 million over five years.

Transgenic mouse model validates mutant IDH2 protein as candidate for targeted anticancer therapies

In recent years, mutations in two metabolic enzymes, isocitrate dehydrogenase-1 and 2 (IDH1 and IDH2), have been identified in approximately 20 percent of all acute myeloid leukemias (AML). As a result, mutant IDH proteins have been proposed as attractive drug targets for this common form of adult leukemia.

Study shows how neutralizing antibodies are produced after SARS-CoV-2 infection

A research group from Osaka University led by Professor Hisashi Arase and consisting of researchers from the Research Institute for Microbial Diseases, the Institute for Protein Research, the Immunology Frontier Research Center, the Center for Infectious Diseases, and the Graduate School of Medicine has discovered for the first time that both neutralizing antibodies that protect against infection as well as infection-enhancing antibodies that increase infectivity are produced after infection with SARS-CoV-2 by analyzing antibodies derived from COVID-19 patients.

Poll: Opposition to health law grows

The Associated Press: "A new Associated Press-GfK poll finds Americans oppose the health care remake 50 percent to 39 percent. Before a divided Congress finally passed the bill and Obama signed it at a jubilant White House ceremony last month, public opinion was about evenly split. Another 10 percent of Americans say they are neutral."

Read more News

› Verified 1 days ago


Suppliers in Colchester, VT

Fahc Outpatient Pharmacy
Type: Pharmacy
Location: 792 College Pkwy 103, Colchester, Vermont 05446
Phone: (802) 847-7461    
Cvs Pharmacy #10216
Type: Durable Medical Equipment & Medical Supplies Supplier
Location: 69 Mountain View Drive, Colchester, Vermont 05446
Phone: (802) 654-0772    
Osco Pharmacy #0615
Type: Durable Medical Equipment & Medical Supplies Supplier
Location: 66 Mountain View Dr, Colchester, Vermont 05446
Phone: (802) 655-2536    
Walgreens #17183
Type: Durable Medical Equipment & Medical Supplies Supplier
Location: 1184 Prim Rd, Colchester, Vermont 05446
Phone: (802) 863-2048    

Medicare Suppliers

Durable Medical Equipment & Medical Supplies

Also referred to as DME Suppliers. A supplier of medical equipment such as respirators, wheelchairs, home dialysis systems, or monitoring systems, that are prescribed by a physician for a patient's use in the home and that are usable for an extended period of time.

Community/Retail Pharmacy

A pharmacy where pharmacists store, prepare, and dispense medicinal preparations and/or prescriptions for a local patient population in accordance with federal and state law; counsel patients and caregivers; administer vaccinations; and provide other professional services associated with pharmaceutical care.

Prosthetic/Orthotic Supplier

An organization that provides prosthetic and orthotic care which may include, but is not limited to, patient evaluation, prosthesis or orthosis design, fabrication, fitting and modification to treat limb loss for purposes of restoring physiological function and/or cosmesis or to treat a neuromusculoskeletal disorder or acquired condition.


Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.